Share on
HTML EMBED
Click to Copy

Latest Episodes

Share on
HTML EMBED
Click to Copy
Share on
HTML EMBED
Click to Copy
Marketplace Morning Report
Share on
HTML EMBED
Click to Copy
Marketplace Morning Report
Share on
HTML EMBED
Click to Copy
Share on
HTML EMBED
Click to Copy
Marketplace
Share on
HTML EMBED
Click to Copy
Marketplace Morning Report
Share on
HTML EMBED
Click to Copy
Marketplace Morning Report
Share on
HTML EMBED
Click to Copy
Marketplace Morning Report
Share on
HTML EMBED
Click to Copy
Share on
HTML EMBED
Click to Copy

Big Pharma could face losses if the newly split government can reach a consensus on drug prices

Ben Bradford Nov 9, 2018
Share Now on:
HTML EMBED:
COPY
Americans continue to spend on drugs at an increasing rate. 
Tim Boyle/Getty Images

There is already public consensus that drug prices are too high. Both Democrats and President Donald Trump have vowed to lower them. Yet, even with a new Democratic majority in the House, they may face challenges lowering pharmaceutical costs. Politically divided governments are often synonymous with gridlock, even on an issue as widely supported as drug prices. For their part, markets are signaling a belief in continued gridlock.

How We Survive
How We Survive
Climate change is here. Experts say we need to adapt. This series explores the role of technology in helping humanity weather the changes ahead.